-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
CNBX Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2024.
- CNBX Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending November 30, 2024 was -$36.8K, a 78.6% increase year-over-year.
- CNBX Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending November 30, 2024 was -$448K, a 40.8% increase year-over-year.
- CNBX Pharmaceuticals Inc. annual Operating Income (Loss) for 2024 was -$583K, a 37.4% increase from 2023.
- CNBX Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$931K, a 68.5% increase from 2022.
- CNBX Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$2.95M, a 13.6% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)